BR2’s Radioisotopes Helped More Than 10 Millions Patients in 2021 In 2021, more than 10 million patients were helped thanks to the production of medical radioisotopes in the Belgian research reactor BR2, as reported the Belgian nuclear research centre SCK CEN (ENS Corporate Member). At each operating cycle, it provides the necessary raw materials used…
SCK CEN and IRE Ready To Start Lutetium-177 Large-Scale Production SCK CEN (ENS Corporate Member) and the National Institute for Radioelements (IRE) are going to start the large-scale production of lutetium-177. This decision opens up opportunities for cancer patients. Lutetium-177 is currently used in hospitals to treat neuroendocrine tumours. Neuroendocrine cells are found primarily in the…
BR2 Research Reactor Will Run With LEU In 2026 SCK CEN (ENS Corporate Member) announced that the BR2 research reactor will switch to low-enriched uranium (LEU) in 2026. Then BR2 will be the world’s first research reactor with high-performance fuel on low enriched uranium. As SCK CEN said, the change to LEU will help to…
SCK CEN Completed The Renovation Of BR2 Research Reactor Last December, SCK CEN (ENS Corporate Member) completed a nine-week renovation of the BR2 research reactor. The works were implemented during a production break from 11 October to 10 December. Among the facility’s modernisations, SCK CEN announced the replacement of ventilation pipes, together with the electrical…